Altre lingue Standard BioTools Inc.

Azioni

LAB

US34385P1084

Tempo reale stimato Cboe BZX Altri mercati azionari 19:25:00 19/04/2024			Variaz. 5gg	Var. 1 gen.
2,535 ^USD	-0,20%		-9,14%	+14,71%

16/04	STANDARD BIOTOOLS INC. : valutazione Buy da parte di TD Cowen	ZM
08/04	Standard BioTools Inc. Introduce nuove modalità di imaging multiplexato ad alta produttività di interi vetrini, destinate a ridefinire i confini dell'imaging tissutale	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging	08/04
Standard BioTools Inc. Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the Boundaries of Tissue Imaging	08/04
Sector Update: Health Care Stocks Lean Higher Pre-Bell Thursday	04/04
Standard BioTools Enters Into Multi-Year Medicine Research Engagement With Bristol-Myers Squibb	04/04
Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research	03/04
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock	18/03
Standard BioTools: Q4 Earnings Snapshot	28/02
Standard BioTools Inc. Provides Revenue Guidance for the Full Year 2024	28/02
Standard BioTools Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02
Standard BioTools Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q4 Revenue $28.2M, vs. Street Est of $24.9M	28/02
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results	28/02
Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing	26/02
Standard BioTools Inc. and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing	26/02
Standard BioTools to Participate in Upcoming Investor Conferences	22/02
Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	14/02
Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine	07/02
Standard Biotools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine	07/02
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue	08/01
Standard Biotools Inc. Provides Revenue Guidance for the Fourth Quarter and full year 2023	08/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Standard BioTools Inc.

Azioni

LAB

US34385P1084

Altre lingue

Filtri